Catalyst Pharmaceuticals
Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.
CPRX Key Statistics
Stock Snapshot
With a market cap of 3.02B, Catalyst Pharmaceuticals(CPRX) trades at $24.71. The stock has a price-to-earnings ratio of 14.66.
On 2026-03-05, Catalyst Pharmaceuticals(CPRX) stock moved within a range of $24.50 to $24.94. With shares now at $24.71, the stock is trading +0.9% above its intraday low and -0.9% below the session's peak.
Trading volume for Catalyst Pharmaceuticals(CPRX) stock has reached 74.96K, versus its average volume of 1.43M.
The stock's 52-week range extends from a low of $19.05 to a high of $26.58.
The stock's 52-week range extends from a low of $19.05 to a high of $26.58.
CPRX News
Investors might want to bet on Catalyst Pharmaceutical (CPRX), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a r...
Advertisement Why Catalyst Pharmaceuticals (CPRX) Is On Investors’ Radar Now Catalyst Pharmaceuticals (CPRX) is in focus after reporting record Q4 and full ye...
Analyst Samantha Semenkow of Citi maintained a Buy rating on Catalyst Pharma, with a price target of $35.00. Claim 50% Off TipRanks Premium Unlock hedge fund-le...
Analyst ratings
100%
of 7 ratingsMore CPRX News
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Catalyst Pharma today and set a price target of $35.00. Andrew Fein has given his Buy rating due...
Catalyst Pharmaceuticals recently reported past fourth-quarter 2025 revenue of US$152.61 million and full-year revenue of US$588.99 million, alongside issuing 2...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.